Allianz Asset Management Gmb H Cytokinetics Inc Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

A detailed history of Allianz Asset Management Gmb H transactions in Cytokinetics Inc stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 5,300 shares of CYTK stock, worth $276,766. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,300

Previous 12,900 58.91%

Holding current value

$276,766

Previous $698,000 60.03%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$51.22 - $60.16 $389,272 - $457,216	-7,600 Reduced 58.91%	5,300 $279,000
Q2 2024 Aug 13, 2024	SELL	$47.86 - $75.05 $210,584 - $330,220	-4,400 Reduced 25.43%	12,900 $698,000
Q1 2024 May 13, 2024	BUY	$63.75 - $108.06 $714,000 - $1.21 Million	11,200 Added 183.61%	17,300 $1.21 Million
Q4 2023 Feb 12, 2024	SELL	$26.88 - $83.49 $255,360 - $793,155	-9,500 Reduced 60.9%	6,100 $509,000
Q2 2023 Aug 11, 2023	BUY	$32.62 - $40.75 $309,890 - $387,125	9,500 Added 155.74%	15,600 $508,000
Q1 2023 May 11, 2023	SELL	$33.36 - $45.71 $366,960 - $502,810	-11,000 Reduced 64.33%	6,100 $214,000
Q4 2022 Feb 13, 2023	SELL	$35.77 - $51.11 $221,094 - $315,910	-6,181 Reduced 26.55%	17,100 $783,000
Q3 2022 Nov 08, 2022	SELL	$38.54 - $54.52 $5.24 Million - $7.41 Million	-135,841 Reduced 85.37%	23,281 $1.13 Million
Q2 2022 Aug 12, 2022	BUY	$33.93 - $48.92 $3.15 Million - $4.54 Million	92,782 Added 139.86%	159,122 $6.25 Million
Q1 2022 May 13, 2022	SELL	$29.74 - $46.0 $2.28 Million - $3.53 Million	-76,797 Reduced 53.65%	66,340 $2.44 Million
Q4 2021 Feb 11, 2022	BUY	$34.35 - $46.38 $4.92 Million - $6.64 Million	143,137 New	143,137 $6.53 Million
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $379,333 - $711,187	-24,858 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$20.58 - $28.96 $511,577 - $719,887	24,858 New	24,858 $538,000
Q3 2018 Nov 13, 2018	SELL	$6.4 - $9.85 $734,022 - $1.13 Million	-114,691 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$6.9 - $9.9 $4,629 - $6,642	-671 Reduced 0.58%	114,691 $952,000
Q1 2018 May 14, 2018	BUY	$7.2 - $10.05 $23,796 - $33,215	3,305 Added 2.95%	115,362 $831,000
Q4 2017 Feb 13, 2018	SELL	$7.25 - $15.65 $10,193 - $22,003	-1,406 Reduced 1.24%	112,057 $913,000
Q3 2017 Nov 13, 2017	BUY	$12.0 - $15.0 $107,100 - $133,875	8,925 Added 8.54%	113,463 $1.65 Million
Q2 2017 Aug 14, 2017	BUY	N/A	20,062 Added 23.75%	104,538 $1.27 Million
Q1 2017 Apr 17, 2019	BUY	N/A	84,476	84,476 $1.09 Million

Others Institutions Holding CYTK

# of Institutions

410

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.92B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Cytokinetics Inc Transaction History